At OCTSC, an expert delved into how to optimise patient enrollment to achieve retention and clinical trial success.
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Abbott ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Zydus ...
"Sponsors should design failure into clinical trials to support patients" was originally created and published by Clinical ...
Patient-reported outcomes (PROs) are widely used in oncology clinical trials to capture patients’ own perspectives on ...
CDMO conglomerate Almac is pouring $48 million into its eClinical offering via an investment that includes the launch of a ...
Introduction Therapeutic exercise has been used to improve cancer-related dysfunction. Recent studies suggest that exercise after chemotherapy can improve cancer-related cognitive impairment. However, ...
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering VesCell™ ...
Sepsis remains one of the leading causes of mortality in hospitalized patients worldwide, and innovative therapeutic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback